News
PAREXEL Named Company of the Year for the Pharmaceuticals Industry with a Gold Stevie from The American Business Awards
PAREXEL International Corporation ,a leading global biopharmaceutical services provider, has been named Company of the Year – Pharmaceuticals in the 14th Annual American Business...
Press Releases
Mylan NV launches generic version of Celgenes Vidaza injection
Mylan N.V. announced the U.S. launch of Azacitidine for Injection, 100 mg/vial, which is a generic version of Celgene's Vidaza® Injection, 100 mg/vial. Mylan...
News
AbbVies Research Commitment to Helping People Living with Rheumatologic Diseases Highlighted Annual EULAR 2016
AbbVie a global biopharmaceutical company announced that data on HUMIRA® (adalimumab), investigational medicines and research, including real-world evidence, aiming to improve clinical outcomes for...
Research Insight
Mylan Launches First Generic of Nuvigil Tablets
Mylan N.V. announced the U.S. launch of Armodafinil Tablets, 50 mg, 150 mg, 250 mg, a generic version of Cephalon's Nuvigil®. Mylan received final...
Industry Reports
Merck to Hold Investor Briefing at 2016 ASCO Annual Meeting
Merck known as MSD outside the United States and Canada, announced that Dr. Roger M. Perlmutter, president, Merck Research Laboratories, will present an overview...
Press Releases
Alexion Pharma (ALXN) Granted Ophand Drug Status in Europe for ALXN1210
Alexion Pharmaceuticals Inc announced that the EC as granted orphan drug designation (ODD) to ALXN1210, a highly innovative, longer-acting C5 antibody being evaluated in...
Press Releases
Bayer collaborates with U.S. National Surgical Adjuvant Breast and Bowel Project to Investigate Stivarga as Adjuvant Therapy in Colon Cancer
Study will include patients with Stage IIIB and IIIC colon cancer who have undergone complete surgical resection of primary tumor and received standard adjuvant...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read